| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.31 | 3e-07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |